Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 11,627 | 10,812 | 12,989 | 13,139 | 4,802 |
| Operating Income | -11,627 | -10,812 | -12,989 | -13,139 | -4,802 |
| Other Income | 152 | 118 | 118 | 100 | 88 |
| Pre-tax Income | -11,475 | -10,694 | -12,871 | -13,039 | -4,714 |
| Net Income Continuous | -11,475 | -10,694 | -12,871 | -13,039 | -4,714 |
| Net Income | $-11,475 | $-10,694 | $-12,871 | $-13,039 | $-4,714 |
| EPS Basic Total Ops | -0.48 | -0.50 | -0.62 | -0.65 | 4.46 |
| EPS Basic Continuous Ops | -0.48 | -0.50 | -0.62 | -0.65 | 3.80 |
| EPS Diluted Total Ops | -0.48 | -0.50 | -0.62 | -0.65 | 4.46 |
| EPS Diluted Continuous Ops | -0.48 | -0.50 | -0.62 | -0.65 | 3.80 |
| EBITDA(a) | $-11,587 | $-10,780 | $-12,962 | $-13,118 | $-4,769 |